Cargando…

Complement Activation Is Associated With Crescents in IgA Nephropathy

INTRODUCTION: Crescents, especially those found at a percentage greater than 50%, are often associated with rapid progression of kidney disease in IgA nephropathy (IgAN). The mechanism of crescents forming in IgAN is still unclear. In this study, we aimed to evaluate whether excess complement activa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zi, Xie, Xinfang, Li, Jingyi, Zhang, Xue, He, Jiawei, Wang, Manliu, Lv, Jicheng, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477028/ https://www.ncbi.nlm.nih.gov/pubmed/34594322 http://dx.doi.org/10.3389/fimmu.2021.676919

Ejemplares similares

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine
por: Xie, Xinfang, et al.
Publicado: (2021)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
por: Li, Huixian, et al.
Publicado: (2021)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)

Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
por: Chen, Ying, et al.
Publicado: (2022)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
por: Di, Dingxin, et al.
Publicado: (2023)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis
por: Niu, Xia, et al.
Publicado: (2023)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
por: Lin, Zaoqiang, et al.
Publicado: (2023)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
por: Ramasamy, Ashok, et al.
Publicado: (2019)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2018)

External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort
por: Zhang, Yuemiao, et al.
Publicado: (2020)

New-onset crescent IgA nephropathy following the CoronaVac vaccine: A case report
por: Ran, Enrong, et al.
Publicado: (2022)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2019)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Functional variant rs12614 in CFB confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese
por: Shi, Dian-Chun, et al.
Publicado: (2022)

Crescents in IgA nephropathy: making the step from prognostic risk factor to therapy target
por: Stefan, Gabriel
Publicado: (2023)

The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
por: Liang, Mengjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6k7hg13p49hq2854og3abmp6nc